ALK and adenocarcinoma: The ALK-testing methods included IHC (30/64, 46.9%), FISH (24/64, 37.5%), PCR (9/64, 14.0%), and NGS (1/64, 1.6%); the mean age of patients was 51.3 years (range 31–70); and 96.9% (62 of 64) of patients were with adenocarcinoma.